A high-level overview of Albireo Pharma, Inc. (ALBO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. The latest closing stock price for Albireo Pharma on March 02, is The all-time high Albireo Pharma closing stock price was on January Stock price for similar companies or competitors ; Albireo Pharma Logo · ORIC Pharmaceuticals. ORIC. 9,11 €, %. The Albireo Pharma, Inc. stock price is currently $ with a total market cap valuation of $ M (M shares outstanding). The Albireo Pharma, Inc. Albireo Pharma's current share price is $ This constitutes a share price movement of % when compared to its closing share.
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat. shares of common stock (the “Shares”) of Albireo Pharma, Inc. (Nasdaq: ALBO) (Albireo) at a price of $ per share, net to the holder in cash, plus one. Real time Albireo Pharma (ALBO) stock price quote, stock graph, news & analysis. What is the market capitalization of Albireo Pharma Inc Stock? As of the May 26, , the market capitalization of Albireo Pharma Inc is M. Albireo Pharma Company Stats As of December Forbes Lists #70 Best Small Cap Companies ()Dropped off in Albireo Pharma Analyst Opinions ; 01/09/23, Wedbush Morgan Securities Inc. Downgraded to Hold ; 10/13/22, H.C. Wainwright & Co. Maintained Buy. The Albireo Pharma Inc stock price today is What Is the Stock Symbol for Albireo Pharma Inc? The stock ticker symbol for Albireo Pharma Inc is ALBO. Is. Real time Albireo Pharma (ALBO) stock price quote, stock graph, news & analysis. Albireo Pharma, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of bile acid modulators. According to Albireo Pharma's latest financial reports and stock price the company's current number of shares outstanding is 19,, At the end of the. Both of these deals are very lucrative, to the point where CinCor's stock rocketed % over the course of the week, and Albireo shot 92% skyward, according to.
Albireo Pharma Inc is listed in the sector of the NASDAQ with ticker ALBO. The last closing price for Albireo Pharma was $ Over the last year, Albireo. Albireo Pharma, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of bile acid modulators. Discover historical prices for BIOD stock on Yahoo Finance. View daily, weekly or monthly format back to when ALBIREO PHARMA INC stock was issued. ALBO * Stock Overview ; Rewards. Revenue is forecast to grow % per year ; Summary of all time highs, changes and price drops for Albireo Pharma. Historical. ALBO Albireo Pharma Inc. 2, $ $ (%). Today. Watchers, 2, Wk Low, $ Wk High, $ Market Cap, $M. Albireo Pharma stock news, updates & related news. Find out why Albireo Pharma's (ALBO) news sentiment is more negative in relation to stocks in the. The average price target for Albireo Pharma is $ This is based on 6 Wall Streets Analysts month price targets, issued in the past 3 months. Albireo Pharma Inc (US:ALBO) has 3 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These. USCVR - CONTRA ALBIREO PHARMA Stock - Stock Price, Institutional Ownership, Shareholders.
Find the latest ALBIREO PHARMA INC (BIOD) stock quote, history, news and other vital information to help you with your stock trading and investing. This stock is no longer active on Robinhood. Sign up for a Robinhood brokerage account to watch Albireo Pharma and buy and sell other stock and options. Biodel Inc. (BIOD) will effect a one for thirty () reverse split of its common stock, change of name to Albireo Pharma, Inc., and a change of symbol to ALBO. Albireo Pharma, Inc. (NASDAQ:ALBO) issued its quarterly earnings results on Thursday, November, 4th. The biopharmaceutical company reported $ earnings per. Share trades for Albireo Pharma Inc-ALBO from Morningstar Trades along with buy and sell volumes for Albireo Pharma Inc-ALBO.
Albireo Pharma Insider Activity ; Carter Martha J. · 01/18/, , 14,, ; Duncan Jason, 01/18/, , 14,, Stock price for similar companies or competitors ; Albireo Pharma Logo. ORIC Pharmaceuticals. ORIC. $, %. According to Albireo Pharma's latest financial reports and stock price the company's current number of shares outstanding is 19,, At the end of the. Historical prices for Albireo Pharma with share price and ALBO stock charts. Free real-time prices, and the most active stock market forums. Should You Buy or Sell Albireo Pharma Stock? Get The Latest ALBO Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at. A high-level overview of Albireo Pharma, Inc. (ALBO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. The latest closing stock price for Albireo Pharma on March 02, is The all-time high Albireo Pharma closing stock price was on January Albireo Pharma Inc is listed in the sector of the NASDAQ with ticker ALBO. The last closing price for Albireo Pharma was $ Over the last year, Albireo. USCVR - CONTRA ALBIREO PHARMA Stock - Stock Price, Institutional Ownership, Shareholders. This stock is no longer active on Robinhood. Sign up for a Robinhood brokerage account to watch Albireo Pharma and buy and sell other stock and options. Albireo Pharma (ALBO) advanced chart and technical analysis tool allows you to add studies and indicators such as Moving Averages (SMA and EMA), MACD. Both of these deals are very lucrative, to the point where CinCor's stock rocketed % over the course of the week, and Albireo shot 92% skyward, according to. ALBO Albireo Pharma Inc. 2, $ $ (%). Today. Watchers, 2, Wk Low, $ Wk High, $ Market Cap, $M. ALBO * Stock Overview ; Rewards. Revenue is forecast to grow % per year ; Summary of all time highs, changes and price drops for Albireo Pharma. Historical. Get the latest Albireo Pharma Inc. (ALBO) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Share trades for Albireo Pharma Inc-ALBO from Morningstar Trades along with buy and sell volumes for Albireo Pharma Inc-ALBO. Albireo Pharma Inc (US:ALBO) has 3 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These. Albireo Fundamentals ; Profit Margin, () % ; Operating Margin, () % ; Current Valuation, M ; Shares Outstanding, M ; Shares Owned By Insiders. shares of common stock (the “Shares”) of Albireo Pharma, Inc. (Nasdaq: ALBO) (Albireo) at a price of $ per share, net to the holder in cash, plus one. Albireo Pharma Inc. ALBO. ANALYTICS. We've crunched the numbers using institutional data. Here are ALBO's fundamentals. Value. Is this stock cheap or. Albireo Pharma Inc ; $ ; % Last Close; Mar 2, ; Trading Volume, 1,, ; Week High/Low ($); - ; Market Cap Full, $ B. Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat. The Albireo Pharma, Inc. stock price is currently $ with a total market cap valuation of $ M (M shares outstanding). The Albireo Pharma, Inc. Albireo Pharma Company Stats As of December Forbes Lists #70 Best Small Cap Companies ()Dropped off in Albireo Pharma's current share price is $ This constitutes a share price movement of % when compared to its closing share. Previous Close. ; Average Volume. K ; Market Cap. M ; Shares Outstanding. M ; EPS (TTM). Biodel Inc. (BIOD) will effect a one for thirty () reverse split of its common stock, change of name to Albireo Pharma, Inc., and a change of symbol to ALBO. Discover historical prices for BIOD stock on Yahoo Finance. View daily, weekly or monthly format back to when ALBIREO PHARMA INC stock was issued. The average price target for Albireo Pharma is $ This is based on 6 Wall Streets Analysts month price targets, issued in the past 3 months. The Albireo Pharma Inc stock price today is What Is the Stock Symbol for Albireo Pharma Inc? The stock ticker symbol for Albireo Pharma Inc is ALBO. Is.